Back to Browse Journals » Virus Adaptation and Treatment » Volume 3

A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome

Authors A Martin Lerner, Safedin Beqaj

Published 21 February 2011 Volume 2011:3 Pages 19—24


Review by Single-blind

Peer reviewer comments 2

A Martin Lerner1, Safedin Beqaj2
1Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA; 2DCL Medical Laboratories, Indianapolis, IN, USA

Abstract: There is no accepted science to relate herpesviruses (Epstein–Barr virus [EBV], human cytomegalovirus [HCMV], and human herpesvirus 6 [HHV6]) as causes of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS patients have elevated serum immunoglobulin (Ig)G serum antibody titers to EBV, HCMV, and HHV6, but there is no herpesvirus DNA-emia, herpesvirus antigenemia, or uniformly elevated IgM serum antibody titers to the complete virions. We propose that herpesvirus EBV, HCMV, and HHV6 immediate-early gene expression in ME/CFS patients leads to host cell dysregulation and host cell apoptosis without lytic herpesvirus replication. Specific antiviral nucleosides, which alleviate ME/CFS, namely valacyclovir for EBV ME/CFS and valganciclovir for HCMV/HHV6 ME/CFS, inhibit herpesvirus DNA polymerases and/or thymidine kinase functions, thus inhibiting lytic virus replication. New host cell recruitment thus ceases. In the absence of new herpesvirus, nonpermissive herpesvirus replication stops, and ME/CFS recovery ensues.

Keywords: ME/CFS, Epstein–Barr virus (EBV), human cytomegalovirus (HCMV), HHV6, abortive replication

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]

Hoggatt J, Tate TA, Pelus LM

International Journal of Nanomedicine 2015, 10:5421-5422

Published Date: 27 August 2015

Patterns of health care utilization for low back pain

Stewart WF, Yan X, Boscarino JA, Maeng DD, Mardekian J, Sanchez RJ, Von Korff MR

Journal of Pain Research 2015, 8:523-535

Published Date: 12 August 2015

Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population

Ding Y, Yang D, Zhou L, Xu J, Chen Y, He P, Yao J, Chen J, Niu H, Sun P, Jin T

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1455-1463

Published Date: 27 July 2015

Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures

Murugan K, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V

International Journal of Nanomedicine 2015, 10:2191-2206

Published Date: 18 March 2015

From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing

Darnall BD, Sturgeon JA, Kao MC, Hah JM, Mackey SC

Journal of Pain Research 2014, 7:219-226

Published Date: 25 April 2014

Water- versus land-based exercise in elderly subjects: effects on physical performance and body composition

Bergamin M, Ermolao A, Tolomio S, Berton L, Sergi G, Zaccaria M

Clinical Interventions in Aging 2013, 8:1109-1117

Published Date: 27 August 2013

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico

García-Alcalá H, Genestier-Tamborero CN, Hirales-Tamez O, Salinas-Palma J, Soto-Vega E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:403-406

Published Date: 19 November 2012

Dynamic contour tonometry in asymmetric glaucoma patients

Suzuki Jr ER, Suzuki CLB, Carlier D, Penha D, Parchen MAR, Batista WD, Agostini Netto J

Clinical Ophthalmology 2012, 6:555-559

Published Date: 11 April 2012

Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae

Darci R Smith, Monica Ogg, Aura Garrison, et al

Virus Adaptation and Treatment 2010, 2:9-20

Published Date: 26 February 2010

Treatment of severe psoriasis with infliximab

JA Leman, AD Burden

Therapeutics and Clinical Risk Management 2008, 4:1165-1175

Published Date: 5 December 2008